Dowzon Pharm to boost exports in Middle East

Published: 2004-02-24 06:56:00

Updated: 2004-02-24 06:56:00

Kim Jae-soo, CEO of a bioventure enterprise Dowzon Pharm and president of Daesung Pharm said on February 20 that it agreed with a certain firm of U.A.E to sign an agreement for the exportation of Momezon, a nutritional dietary supplement which is effective for diabetes and various kinds of diseas...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK